Kaku K, Shimoda M, Osonoi T, Iwamoto M, et al. Efficacy and safety of imeglimin add-on to DPP-4 inhibitor therapy in Japanese patients with type 2 diabetes mellitus: An interim analysis of the randomised, double-blind FAMILIAR trial. Diabetes Obes Metab 2025 Mar 21. doi: 10.1111/dom.16336.
PMID: 40116188